Revance Therapeutics Inc

NASDAQ:RVNC   2:24:07 PM EDT
24.74
+0.19 (+0.77%)
Products

Revance Announces FDA Approval Of Daxxify™ (Daxibotulinumtoxina-Lanm) For Injection, The First And Only Peptide-Formulated Neuromodulator With Long-Lasting Results

Published: 09/08/2022 12:46 GMT
Revance Therapeutics Inc (RVNC) - Revance Announces FDA Approval of Daxxify™ (daxibotulinumtoxina-lanm) for Injection, the First and Only Peptide-formulated Neuromodulator With Long-lasting Results.